Eric Coldwell
Stock Analyst at Robert W. Baird
(4.53)
# 991
Out of 4,463 analysts
780
Total ratings
58.4%
Success rate
7.4%
Average return
Main Sectors:
Stocks Rated by Eric Coldwell
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IQV IQVIA Holdings | Maintained: Buy | $258 → $249 | $202.24 | +23.12% | 67 | Jul 1, 2026 | |
| ICLR ICON Public Limited Company | Maintained: Buy | $168 → $186 | $175.37 | +6.06% | 70 | Jun 25, 2026 | |
| MDLN Medline | Maintained: Buy | $56 → $45 | $40.68 | +10.62% | 3 | Jun 2, 2026 | |
| ACH Accendra Health | Maintained: Buy | $7 → $6 | $3.49 | +71.92% | 72 | May 12, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $193 → $213 | $230.00 | -7.39% | 70 | May 8, 2026 | |
| MCK McKesson | Maintained: Buy | $974 → $941 | $757.92 | +24.16% | 77 | May 8, 2026 | |
| COR Cencora | Maintained: Buy | $415 → $339 | $283.98 | +19.37% | 74 | May 7, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $16 → $18 | $10.72 | +67.91% | 40 | May 6, 2026 | |
| FTRE Fortrea Holdings | Maintained: Buy | $16 → $20 | $18.20 | +9.89% | 14 | May 6, 2026 | |
| CAH Cardinal Health | Maintained: Buy | $252 → $248 | $236.56 | +4.84% | 69 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $326 → $334 | $283.00 | +18.02% | 73 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $564 → $477 | $543.29 | -12.20% | 58 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $219 → $229 | $214.00 | +7.01% | 59 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $103.28 | n/a | 28 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $23 → $22 | $4.40 | n/a | 6 | May 9, 2014 |
IQVIA Holdings
Jul 1, 2026
Maintained: Buy
Price Target: $258 → $249
Current: $202.24
Upside: +23.12%
ICON Public Limited Company
Jun 25, 2026
Maintained: Buy
Price Target: $168 → $186
Current: $175.37
Upside: +6.06%
Medline
Jun 2, 2026
Maintained: Buy
Price Target: $56 → $45
Current: $40.68
Upside: +10.62%
Accendra Health
May 12, 2026
Maintained: Buy
Price Target: $7 → $6
Current: $3.49
Upside: +71.92%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $193 → $213
Current: $230.00
Upside: -7.39%
McKesson
May 8, 2026
Maintained: Buy
Price Target: $974 → $941
Current: $757.92
Upside: +24.16%
Cencora
May 7, 2026
Maintained: Buy
Price Target: $415 → $339
Current: $283.98
Upside: +19.37%
AdaptHealth
May 6, 2026
Maintained: Buy
Price Target: $16 → $18
Current: $10.72
Upside: +67.91%
Fortrea Holdings
May 6, 2026
Maintained: Buy
Price Target: $16 → $20
Current: $18.20
Upside: +9.89%
Cardinal Health
May 1, 2026
Maintained: Buy
Price Target: $252 → $248
Current: $236.56
Upside: +4.84%
May 1, 2026
Maintained: Buy
Price Target: $326 → $334
Current: $283.00
Upside: +18.02%
Apr 24, 2026
Maintained: Buy
Price Target: $564 → $477
Current: $543.29
Upside: -12.20%
Apr 22, 2026
Maintained: Hold
Price Target: $219 → $229
Current: $214.00
Upside: +7.01%
Apr 18, 2022
Maintained: Hold
Price Target: $110
Current: $103.28
Upside: n/a
May 9, 2014
Rated: Buy
Price Target: $23 → $22
Current: $4.40
Upside: n/a